![Frank L. Porfido](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank L. Porfido
No open positions remaining
Profile
Frank L.
Porfido held the position of Chief Financial Officer at Tyme Technologies, Inc. in 2021 and Vice President-Finance at UroGen Pharma, Inc. from 2019 to 2021.
He earned an MBA from Fairleigh Dickinson University and an undergraduate degree from Pace University.
Former positions of Frank L. Porfido
| Companies | Position | End |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Director of Finance/CFO | 2022-09-15 |
UroGen Pharma, Inc.
 UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Corporate Officer/Principal | 2021-04-30 |
Training of Frank L. Porfido
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UroGen Pharma, Inc.
UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Health Technology |
- Stock Market
- Insiders
- Frank L. Porfido
Choose MarketScreener 
